Резолюция промежуточного Совещания экспертного совета по результатам исследования empa-reg outcome
2016
The interdisciplinary interim experts' council on March 3, 2016 in Moscow have considered the EMPA-REG OUTCOME trial results and suggested a number of propositions and recommendations on further empagliflozin's cardiovascular effects investigation and its clinical application in patients with type 2 diabetes at high cardiovascular risk.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI